NEW YORK, April 9 – Spotfire said Monday that it has signed agreements with both Celera and Biogen for use of Spotfire’s DecisionSite analytical software.

Celera and Spotfire will integrate DecisionSite, which enables visual analysis of product, process, and customer information from a variety of sources, with the Celera Discovery System, which provides access to Celera’s human, mouse, and fly genomes as well as other biological databases. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times profiles 23andMe's Anne Wojcicki and describes how she bounced back from a bad year.

Fotis Kafatos, the founding president of the European Research Council, has died, according to the Associated Press.

In PLOS this week: genomic analysis of honeybee disease, microRNA profiles of people with lupus nephritis, and more.

The Verge's Angela Chen tried out a gene test for fitness advice, but didn't learn much new information.